102 related articles for article (PubMed ID: 31585769)
1. Structural Mechanisms Underlying Activity Changes in an AMPA-type Glutamate Receptor Induced by Substitutions in Its Ligand-Binding Domain.
Sakakura M; Ohkubo Y; Oshima H; Re S; Ito M; Sugita Y; Takahashi H
Structure; 2019 Nov; 27(11):1698-1709.e5. PubMed ID: 31585769
[TBL] [Abstract][Full Text] [Related]
2. Population Shift Mechanism for Partial Agonism of AMPA Receptor.
Oshima H; Re S; Sakakura M; Takahashi H; Sugita Y
Biophys J; 2019 Jan; 116(1):57-68. PubMed ID: 30573176
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of cleft closure of the GluA2 ligand-binding domain in the presence of full and partial agonists revealed by hydrogen-deuterium exchange.
Ahmed AH; Ptak CP; Fenwick MK; Hsieh CL; Weiland GA; Oswald RE
J Biol Chem; 2013 Sep; 288(38):27658-27666. PubMed ID: 23940029
[TBL] [Abstract][Full Text] [Related]
4. The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.
Holley SM; Ahmed AH; Srinivasan J; Murthy SE; Weiland GA; Oswald RE; Nowak LM
Biochemistry; 2012 May; 51(19):4015-27. PubMed ID: 22512472
[TBL] [Abstract][Full Text] [Related]
5. Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
Birdsey-Benson A; Gill A; Henderson LP; Madden DR
J Neurosci; 2010 Jan; 30(4):1463-70. PubMed ID: 20107073
[TBL] [Abstract][Full Text] [Related]
6. Role of conformational dynamics in α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor partial agonism.
Ramaswamy S; Cooper D; Poddar N; MacLean DM; Rambhadran A; Taylor JN; Uhm H; Landes CF; Jayaraman V
J Biol Chem; 2012 Dec; 287(52):43557-64. PubMed ID: 23115239
[TBL] [Abstract][Full Text] [Related]
7. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
8. A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators.
Harms JE; Benveniste M; Kessler M; Stone LM; Arai AC; Partin KM
J Biol Chem; 2014 Apr; 289(15):10702-10714. PubMed ID: 24550387
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
Armstrong N; Gouaux E
Neuron; 2000 Oct; 28(1):165-81. PubMed ID: 11086992
[TBL] [Abstract][Full Text] [Related]
10. Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.
Madden DR; Cheng Q; Thiran S; Rajan S; Rigo F; Keinänen K; Reinelt S; Zimmermann H; Jayaraman V
Biochemistry; 2004 Dec; 43(50):15838-44. PubMed ID: 15595838
[TBL] [Abstract][Full Text] [Related]
11. On the mechanisms of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor binding to glutamate and kainate.
Fenwick MK; Oswald RE
J Biol Chem; 2010 Apr; 285(16):12334-43. PubMed ID: 20110361
[TBL] [Abstract][Full Text] [Related]
12. Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.
Gill A; Birdsey-Benson A; Jones BL; Henderson LP; Madden DR
Biochemistry; 2008 Dec; 47(52):13831-41. PubMed ID: 19102704
[TBL] [Abstract][Full Text] [Related]
13. AMPA receptor binding cleft mutations that alter affinity, efficacy, and recovery from desensitization.
Robert A; Armstrong N; Gouaux JE; Howe JR
J Neurosci; 2005 Apr; 25(15):3752-62. PubMed ID: 15829627
[TBL] [Abstract][Full Text] [Related]
14. Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.
Mankiewicz KA; Rambhadran A; Du M; Ramanoudjame G; Jayaraman V
Biochemistry; 2007 Feb; 46(5):1343-9. PubMed ID: 17260963
[TBL] [Abstract][Full Text] [Related]
15. Structural landscape of isolated agonist-binding domains from single AMPA receptors.
Landes CF; Rambhadran A; Taylor JN; Salatan F; Jayaraman V
Nat Chem Biol; 2011 Mar; 7(3):168-73. PubMed ID: 21297640
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of partial agonism in AMPA-type glutamate receptors.
Salazar H; Eibl C; Chebli M; Plested A
Nat Commun; 2017 Feb; 8():14327. PubMed ID: 28211453
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2.
Okada O; Odai K; Sugimoto T; Ito E
Biophys Chem; 2012 Mar; 162():35-44. PubMed ID: 22284903
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced isomerization in a glutamate receptor ligand-binding domain. A kinetic and mutagenetic analysis.
Abele R; Keinanen K; Madden DR
J Biol Chem; 2000 Jul; 275(28):21355-63. PubMed ID: 10748170
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
Hogner A; Kastrup JS; Jin R; Liljefors T; Mayer ML; Egebjerg J; Larsen IK; Gouaux E
J Mol Biol; 2002 Sep; 322(1):93-109. PubMed ID: 12215417
[TBL] [Abstract][Full Text] [Related]
20. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
